Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文（繁體）
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Research Assistant Yui HUI
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor HUI Yui
Personal Information
CUHK Research Outputs
1 of 3
Liver cirrhosis–specific glycoforms of serum proteins in chronic hepatitis B infection: Identification by lectin affinity chromatography and quantitative proteomic profiling
(
2015
)
Targeted hepatitis C screening among ex-injection drug users in the community
(
2014
)
Identification of liver cirrhosis-specific glycoforms of serum proteins from patients with chronic hepatitis B infection by differential lectin affinity chromatography and quantitative proteomic profiling
(
2010
)
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
(
2009
)
Serum total glycosylation profiling for non-invasive diagnosis of liver cirrhosis in people with chronic hepatitis B
(
2009
)
Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B
(
2009
)
Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B
(
2009
)
Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice
(
2008
)
Health-related quality of life in Chinese patients with primary biliary cirrhosis
(
2008
)
Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBe-Ag)-positive chronic hepatitis B
(
2008
)
Rapid diagnosis of Wilson disease by a 28-mutation panel: Real-time amplification refractory mutation system in diagnosing acute Wilsonian liver failure
(
2008
)
Validation of NAFLD fibrosis score in a less obese population with low prevalence of advanced fibrosis
(
2008
)
Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis
(
2008
)
Validation of the NAFLD fibrosis score in a less obese population with low prevalence of advanced fibrosis
(
2008
)
Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B
(
2008
)
Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis
(
2007
)
High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis
(
2007
)
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis
(
2007
)
Rapid HBV DNA suppression can predict response to peginterferon and lamivudine combination treatment
(
2007
)
Rapid viral suppression can predict sustained virological response to peginterferon and lamivudine combination treatment in chronic hepatitis B
(
2007
)
Simultaneous peginterferon and lamivudine combination suppresses HBV faster than staggered regimes
(
2007
)
Virological response to differenet combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B
(
2007
)
Application of total serum N-glycome profiling to diagnosis of liver fibrosis and cirrhosis in patients with chronic hepatitis B infection
(
2006
)
A study of serum and intrahepatic HBV DNA on different combination treatment regimes of peginterferon alpha-2B and lamivudine for chronic hepatitis B
(
2006
)
Effect of celecoxib on experimental liver fibrosis in rat
(
2006
)
Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B
(
2006
)
Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B
(
2006
)
Genetic polymorphisms of interleukin-1-beta in association with sustained response to anti-viral treatment in chronic hepatitis B in Chinese
(
2006
)
Interleukin-1-beta gene polymorphism is associated with sustained response to anti-viral treatment in chronic hepatitis B
(
2006
)
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B
(
2006
)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
(
2006
)
Metabolic and adipokine profile of Chinese patients with non-alcoholic fatty liver disease
(
2006
)
Post-challenge hyperglycemia is common among Chinese patients with nonalcoholic fatty liver disease and is associated with histological severity
(
2006
)
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease
(
2006
)
Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy
(
2006
)
Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach
(
2006
)
Virodynamic predictors of treatment response to peginterferon and lamivudine combination treatment of HBeAg-positive chronic hepatitis B
(
2006
)
A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients
(
2005
)
Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell
(
2005
)
A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-alpha 2b and lamivudine with lamivudine alone
(
2005
)
A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients
(
2005
)
Histological progression of non-alcoholic fatty liver disease in Chinese patients
(
2005
)
Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model
(
2005
)
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
(
2005
)
Intrahepatic hepatitis B virus covalently closed circular DNA can predict sustained virological response to anti-viral treatment
(
2005
)
Liver-specific overexpression of cyclooxygenase-2 is protective against carbon tetrachloride-induced liver fibrosis in transgenic mice
(
2005
)
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
(
2005
)
MELD Score is an Inferior Model to Child-Pugh Score to Predict Mortality in Decompensated Chronic Hepatitis B
(
2005
)
Noninvasive Prediction of Liver Fibrosis and Cirrhosis by Serum Proteomic Fingerprinting
(
2005
)
Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: A pilot study
(
2005
)
Share Link
Last updated on 2019-16-08 at 06:35
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
